MedTrace Logo

Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women

NCT03770065 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2020-10-06

No results posted yet for this study

Summary

The study is designed to determine the effect on vaginal pH and the duration of action measured on the ability of the base formulation to reduce the vaginal pH

Conditions

  • Vaginal Atrophy

Interventions

DEVICE

VML-0001

Medical device

Sponsors & Collaborators

  • Viramal Limited

    lead INDUSTRY

Principal Investigators

  • James Murray, MD · Doctor

Eligibility

Min Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-19
Primary Completion
2019-12-30
Completion
2020-04-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03770065 on ClinicalTrials.gov